Stuart K - Search Results

1

The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial.

Adams LA, Crawford DH, Stuart K, House MJ, St Pierre TG, Webb M, Ching HL, Kava J, Bynevelt M, MacQuillan GC, Garas G, Ayonrinde OT, Mori TA, Croft KD, Niu X, Jeffrey GP, Olynyk JK. Adams LA, et al. Among authors: stuart k. Hepatology. 2015 May;61(5):1555-64. doi: 10.1002/hep.27662. Epub 2015 Mar 20. Hepatology. 2015. PMID: 25524401 Clinical Trial.

2

The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.

Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth LA, Cooksley WG, Powell LW, Crawford DH. Stuart KA, et al. J Hepatol. 1998 Mar;28(3):404-9. doi: 10.1016/s0168-8278(98)80313-9. J Hepatol. 1998. PMID: 9551677

3

Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation.

Stuart KA, Fletcher LM, Clouston AD, Lynch SV, Purdie DM, Kerlin P, Crawford DH. Stuart KA, et al. Hepatology. 2000 Dec;32(6):1200-7. doi: 10.1053/jhep.2000.20348. Hepatology. 2000. PMID: 11093725

4

Duodenal expression of iron transport molecules in untreated haemochromatosis subjects.

Stuart KA, Anderson GJ, Frazer DM, Powell LW, McCullen M, Fletcher LM, Crawford DH. Stuart KA, et al. Gut. 2003 Jul;52(7):953-9. doi: 10.1136/gut.52.7.953. Gut. 2003. PMID: 12801950 Free PMC article.

5

Increased duodenal expression of divalent metal transporter 1 and iron-regulated gene 1 in cirrhosis.

Stuart KA, Anderson GJ, Frazer DM, Murphy TL, Powell LW, Fletcher LM, Crawford DH. Stuart KA, et al. Hepatology. 2004 Feb;39(2):492-9. doi: 10.1002/hep.20038. Hepatology. 2004. PMID: 14768003

6

Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis.

Crawford DH, Fletcher LM, Hubscher SG, Stuart KA, Gane E, Angus PW, Jeffrey GP, McCaughan GW, Kerlin P, Powell LW, Elias EE. Crawford DH, et al. Hepatology. 2004 Jun;39(6):1655-62. doi: 10.1002/hep.20242. Hepatology. 2004. PMID: 15185307

7

Adding serum sodium to model for end-stage liver disease: identifying those most at risk.

Crawford DH, Stuart K. Crawford DH, et al. Among authors: stuart k. J Gastroenterol Hepatol. 2009 Dec;24(12):1804-6. doi: 10.1111/j.1440-1746.2009.06028.x. J Gastroenterol Hepatol. 2009. PMID: 20002937 No abstract available.

8

Serum ferritin concentration predicts mortality in patients awaiting liver transplantation.

Walker NM, Stuart KA, Ryan RJ, Desai S, Saab S, Nicol JA, Fletcher LM, Crawford DH. Walker NM, et al. Hepatology. 2010 May;51(5):1683-91. doi: 10.1002/hep.23537. Hepatology. 2010. PMID: 20225256

9

Interaction of serum ferritin and body mass index in patients with chronic hepatitis B: improved prediction of cirrhosis.

Paul S, O'Regan K, St John A, Stuart K, Crawford D. Paul S, et al. Among authors: stuart k. Hepatology. 2013 May;57(5):2094-5. doi: 10.1002/hep.26076. Epub 2012 Dec 12. Hepatology. 2013. PMID: 22987244 No abstract available.

10

Liver transplantation outcomes for Australian Aboriginal and Torres Strait Islanders.

Chinnaratha MA, Chelvaratnam U, Stuart KA, Strasser SI, McCaughan GW, Gow P, Adams LA, Wigg AJ; Australia and New Zealand Liver Transplant Clinical Study Group. Chinnaratha MA, et al. Liver Transpl. 2014 Jul;20(7):798-806. doi: 10.1002/lt.23894. Liver Transpl. 2014. PMID: 24753233 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

657 results

Search Page

Filters